- Home
- Publications
- Publication Search
- Publication Details
Title
Genome Editing for Mucopolysaccharidoses
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 2, Pages 500
Publisher
MDPI AG
Online
2020-01-15
DOI
10.3390/ijms21020500
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of preexisting adaptive immunity to Cas9 proteins in humans
- (2019) Carsten T. Charlesworth et al. NATURE MEDICINE
- EMPOWERS: A phase 1/2 clinical trial of SB-318 ZFN-mediated in vivo human genome editing for treatment of MPS I (Hurler syndrome)
- (2019) Paul Harmatz et al. MOLECULAR GENETICS AND METABOLISM
- CHAMPIONS: A phase 1/2 clinical trial with dose escalation of SB-913 ZFN-mediated in vivo human genome editing for treatment of MPS II (Hunter syndrome)
- (2019) Joseph Muenzer et al. MOLECULAR GENETICS AND METABOLISM
- Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response
- (2019) Giulia Schiroli et al. Cell Stem Cell
- Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future
- (2019) Madeleine Taylor et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Induced Pluripotent Stem Cell Derivation and Ex Vivo Gene Correction Using a Mucopolysaccharidosis Type 1 Disease Mouse Model
- (2019) Toshio Miki et al. Stem Cells International
- Search-and-replace genome editing without double-strand breaks or donor DNA
- (2019) Andrew V. Anzalone et al. NATURE
- Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I
- (2019) Natalia Gomez-Ospina et al. Nature Communications
- Neonatal nonviral gene editing with the CRISPR/Cas9 system improves some cardiovascular, respiratory, and bone disease features of the mucopolysaccharidosis I phenotype in mice
- (2019) Roselena Silvestri Schuh et al. GENE THERAPY
- UDiTaS™, a genome editing detection method for indels and genome rearrangements
- (2018) Georgia Giannoukos et al. BMC GENOMICS
- Worldwide distribution of common IDUA pathogenic variants
- (2018) E. Poletto et al. CLINICAL GENETICS
- Gene editing of MPS I human fibroblasts by co-delivery of a CRISPR/Cas9 plasmid and a donor oligonucleotide using nanoemulsions as nonviral carriers
- (2018) Roselena Silvestri Schuh et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- A novel Blind Start study design to investigate vestronidase alfa for mucopolysaccharidosis VII, an ultra-rare genetic disease
- (2018) Paul Harmatz et al. MOLECULAR GENETICS AND METABOLISM
- A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II
- (2018) Hiroyuki Sonoda et al. MOLECULAR THERAPY
- Dose-Dependent Prevention of Metabolic and Neurologic Disease in Murine MPS II by ZFN-Mediated In Vivo Genome Editing
- (2018) Kanut Laoharawee et al. MOLECULAR THERAPY
- p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells
- (2018) Robert J. Ihry et al. NATURE MEDICINE
- CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response
- (2018) Emma Haapaniemi et al. NATURE MEDICINE
- Gene Editing on Center Stage
- (2018) Rasmus O. Bak et al. TRENDS IN GENETICS
- CtIP fusion to Cas9 enhances transgene integration by homology-dependent repair
- (2018) M. Charpentier et al. Nature Communications
- Covalent linkage of the DNA repair template to the CRISPR-Cas9 nuclease enhances homology-directed repair
- (2018) Natasa Savic et al. eLife
- Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population
- (2018) Vijaya L. Simhadri et al. Molecular Therapy-Methods & Clinical Development
- Emerging Issues in AAV-Mediated In Vivo Gene Therapy
- (2018) Pasqualina Colella et al. Molecular Therapy-Methods & Clinical Development
- CRISPR-Cas9-mediated gene editing in human MPS I fibroblasts
- (2018) Talita Giacomet de Carvalho et al. GENE
- In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system
- (2018) Roselena Silvestri Schuh et al. JOURNAL OF CONTROLLED RELEASE
- Cas9-mediated allelic exchange repairs compound heterozygous recessive mutations in mice
- (2018) Dan Wang et al. NATURE BIOTECHNOLOGY
- A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
- (2018) Christopher A. Vakulskas et al. NATURE MEDICINE
- Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with β-Thalassemia Major
- (2018) Nikoletta Psatha et al. Molecular Therapy-Methods & Clinical Development
- ZFN-Mediated In Vivo Genome Editing Corrects Murine Hurler Syndrome
- (2018) Li Ou et al. MOLECULAR THERAPY
- Sangamo's landmark genome editing trial gets mixed reception
- (2018) Cormac Sheridan NATURE BIOTECHNOLOGY
- Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration
- (2017) Kyoungmi Kim et al. GENOME RESEARCH
- Integrating Vectors for Gene Therapy and Clonal Tracking of Engineered Hematopoiesis
- (2017) Luca Biasco et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Genome and Epigenome Editing to Treat Disorders of the Hematopoietic System
- (2017) Claudio Mussolino et al. HUMAN GENE THERAPY
- Brain and Organ Uptake in the Rhesus Monkey in Vivo of Recombinant Iduronidase Compared to an Insulin Receptor Antibody–Iduronidase Fusion Protein
- (2017) Ruben J. Boado et al. MOLECULAR PHARMACEUTICS
- Hematopoietic Stem Cell Gene Therapy for Storage Disease: Current and New Indications
- (2017) Alessandra Biffi MOLECULAR THERAPY
- Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
- (2017) Nicole M. Gaudelli et al. NATURE
- Genome-wide target specificities of CRISPR RNA-guided programmable deaminases
- (2017) Daesik Kim et al. NATURE BIOTECHNOLOGY
- CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR–Cas9 nuclease off-targets
- (2017) Shengdar Q Tsai et al. NATURE METHODS
- Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy
- (2017) Leonela Amoasii et al. Science Translational Medicine
- Preclinical Testing of the Safety and Tolerability of Lentiviral Vector–Mediated Above-Normal Alpha-L-Iduronidase Expression in Murine and Human Hematopoietic Cells Using Toxicology and Biodistribution Good Laboratory Practice Studies
- (2016) Ilaria Visigalli et al. HUMAN GENE THERAPY
- Clinical course of sly syndrome (mucopolysaccharidosis type VII)
- (2016) Adriana M Montaño et al. JOURNAL OF MEDICAL GENETICS
- Hematopoietic stem cell transplantation for Morquio A syndrome
- (2016) Hiromasa Yabe et al. MOLECULAR GENETICS AND METABOLISM
- CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
- (2016) Daniel P. Dever et al. NATURE
- High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
- (2016) Benjamin P. Kleinstiver et al. NATURE
- Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells
- (2016) M. A. DeWitt et al. Science Translational Medicine
- Enrichment of G2/M cell cycle phase in human pluripotent stem cells enhances HDR-mediated gene repair with customizable endonucleases
- (2016) Diane Yang et al. Scientific Reports
- Hematopoietic Cell Transplantation for Mucopolysaccharidosis Patients Is Safe and Effective: Results after Implementation of International Guidelines
- (2015) Mieke Aldenhoven et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- In vivo genome editing of the albumin locus as a platform for protein replacement therapy
- (2015) R. Sharma et al. BLOOD
- Cord blood is the optimal graft source for the treatment of pediatric patients with lysosomal storage diseases: clinical outcomes and future directions
- (2015) Mieke Aldenhoven et al. CYTOTHERAPY
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining
- (2015) Takeshi Maruyama et al. NATURE BIOTECHNOLOGY
- Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
- (2015) Ayal Hendel et al. NATURE BIOTECHNOLOGY
- Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells
- (2015) Van Trung Chu et al. NATURE BIOTECHNOLOGY
- Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells
- (2015) Daesik Kim et al. NATURE METHODS
- Rationally engineered Cas9 nucleases with improved specificity
- (2015) I. M. Slaymaker et al. SCIENCE
- Pharmacological inhibition of DNA-PK stimulates Cas9-mediated genome editing
- (2015) Francis Robert et al. Genome Medicine
- Gene delivery strategies for the treatment of mucopolysaccharidoses
- (2014) Guilherme Baldo et al. Expert Opinion on Drug Delivery
- The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders.
- (2014) K Wyatt et al. HEALTH TECHNOLOGY ASSESSMENT
- Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study
- (2014) Christian J. Hendriksz et al. JOURNAL OF INHERITED METABOLIC DISEASE
- GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
- (2014) Shengdar Q Tsai et al. NATURE BIOTECHNOLOGY
- Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases
- (2014) Richard L Frock et al. NATURE BIOTECHNOLOGY
- The new frontier of genome engineering with CRISPR-Cas9
- (2014) J. A. Doudna et al. SCIENCE
- Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
- (2014) Steven Lin et al. eLife
- COSMID: A Web-based Tool for Identifying and Validating CRISPR/Cas Off-target Sites
- (2014) Thomas J Cradick et al. Molecular Therapy-Nucleic Acids
- Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients
- (2013) David G Ousterout et al. MOLECULAR THERAPY
- Outcomes of haematopoietic stem cell transplantation for inherited metabolic disorders: A report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry
- (2013) R. Mitchell et al. PEDIATRIC TRANSPLANTATION
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- RNA-programmed genome editing in human cells
- (2013) Martin Jinek et al. eLife
- Mucopolysacccharidoses: from understanding to treatment, a century of discoveries
- (2012) Roberto Giugliani GENETICS AND MOLECULAR BIOLOGY
- An exploratory study of brain function and structure in mucopolysaccharidosis type I: Long term observations following hematopoietic cell transplantation (HCT)
- (2012) Elsa Shapiro et al. MOLECULAR GENETICS AND METABOLISM
- Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: A nationwide survey in Japan
- (2012) Akemi Tanaka et al. MOLECULAR GENETICS AND METABOLISM
- Evaluation of miglustat as maintenance therapy after enzyme therapy in adults with stable type 1 Gaucher disease: a prospective, open-label non-inferiority study
- (2012) Timothy M Cox et al. Orphanet Journal of Rare Diseases
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Genistein in Sanfilippo disease: A randomized controlled crossover trial
- (2011) Jessica de Ruijter et al. ANNALS OF NEUROLOGY
- Enzyme replacement therapy for lysosomal storage diseases
- (2011) Robin H. Lachmann CURRENT OPINION IN PEDIATRICS
- Over-expression of RAD51 or RAD54 but not RAD51/4 enhances extra-chromosomal homologous recombination in the human sarcoma (HT-1080) cell line
- (2011) Shengli Yu et al. JOURNAL OF BIOTECHNOLOGY
- Evaluation of Miglustat Treatment in Patients with Type III Mucopolysaccharidosis: A Randomized, Double-Blind, Placebo-Controlled Study
- (2011) Nathalie Guffon et al. JOURNAL OF PEDIATRICS
- An unbiased genome-wide analysis of zinc-finger nuclease specificity
- (2011) Richard Gabriel et al. NATURE BIOTECHNOLOGY
- Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study
- (2010) E. Lukina et al. BLOOD
- Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model
- (2010) I. Visigalli et al. BLOOD
- Genome editing with engineered zinc finger nucleases
- (2010) Fyodor D. Urnov et al. NATURE REVIEWS GENETICS
- Guidelines for the Management of Mucopolysaccharidosis Type I
- (2009) Ana Maria Martins et al. JOURNAL OF PEDIATRICS
- Improved Metabolic Correction in Patients with Lysosomal Storage Disease Treated with Hematopoietic Stem Cell Transplant Compared with Enzyme Replacement Therapy
- (2009) Robert F. Wynn et al. JOURNAL OF PEDIATRICS
- Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice
- (2009) Marcelina Malinowska et al. MOLECULAR GENETICS AND METABOLISM
- Strategies to Modulate Immune Responses: A New Frontier for Gene Therapy
- (2009) Valder R Arruda et al. MOLECULAR THERAPY
- Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment
- (2008) Jinhai Wang et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now